In addition to inhibition of apoptosis, activated NF-κB may control cell cycle progression by regulating the expression of important cell cycle regulatory proteins such as cyclin D1 and cyclin dependent kinase 2 (CDK2), further contributing to the tumour growth [40]. The gene discussed is CDK2; the disease is neoplasm.